A look at the shareholders of Abbott Laboratories (NYSE:ABT) can tell us which group is most powerful. We can see that institutions own the lion's share in the company with 78% ownership.

The projected fair value for Abbott Laboratories is US$137 based on 2 Stage Free Cash Flow to Equity Abbott Laboratories' US$119 share price indicates it is trading at similar levels as its fair ...

Earnings Report 1.110 USD Q4 2021 Earnings Release 01/26/2022 Indices Commodities Currencies Stocks ...

This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...

Oppenheimer has recently initiated Abbott Laboratories (ABT) stock to Outperform rating, as announced on October 8, 2024, according to Finviz. Earlier, on September 19, 2024, Piper Sandler had ...

Abbott Laboratories (NYSE:ABT) manufacturers and sells medical and healthcare related products in more than 160 countries. Originally started by Dr. Wallace Abbott as a means of developing high ...

In the last three months, 15 analysts have published ratings on Abbott Laboratories (NYSE:ABT), offering a diverse range of perspectives from bullish to bearish. The table below summarizes their ...

ABT stock opened at $118.60 on Thursday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.18 and a current ratio of 1.68. The firm has a market cap of $206.35 billion, a price-to ...

Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Abbott Laboratories (ABT – Research Report) yesterday and set a price target of $133.00. The company’s shares closed yesterday at ...

Copyright © 2024 MarketWatch, Inc. All rights reserved.